Companies / Puerto Rico
BMS To Expand In Puerto Rico
April 2006 | FDI AlertUS pharmaceutical firm Bristol-Myers Squibb (BMS) is to invest a further US$200mn in its Puerto Rican manufacturing facility. The expansion at Manati will focus on steriles packaging and production of biotech products such as new rheumatoid arthritis drug Orencia (abatacept). Puerto Rico has recently improved incentives and exemptions for so-called 'pioneer' companies, with recent major investments in the US territory recently outlined by major firms including Amgen, Abbott Laboratories and Eli Lilly.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
